AbbottC, VileikyteL, WilliamsonS, et al: Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care21: 1071, 1998.965359710.2337/diacare.21.7.1071)| false
PetersEJ, LaveryLA; International Working Group on the Diabetic Foot: Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care24: 1442, 2001.
PetersEJ, LaveryLA; International Working Group on the Diabetic Foot: Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care24: 1442, 2001.10.2337/diacare.24.8.1442)| false
CaselliA, PhamH, GiuriniJ, et al: The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care25: 1066, 2002.1203211610.2337/diacare.25.6.1066)| false
LaveryLA, ArmstrongDG, WunderlichRP, et al: Predictive value of foot pressure assessment as part of a population based diabetes disease management program. Diabetes Care26: 1069, 2003.10.2337/diacare.26.4.106912663575)| false
SandersJ, GreveJ, MitchellS, et al: Material properties of commonly-used interface materials and their static coefficiants of friction with skin and socks. J Rehabil Res Dev35: 161, 1998.9651888)| false
LobmannR, KayserR, KastenG, et al: Effects of preventative footwear on foot pressure as determined by pedobarography in diabetic patients: a prospective study. Diabet Med18: 314, 2001.10.1046/j.1464-5491.2001.00482.x11437863)| false
OlaleyeD, PerkinsB, BrilV:Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract54: 115, 2001.10.1016/S0168-8227(01)00278-9)| false
CowleyMS, BoykoEJ, ShoferJB, et al: Foot ulcer risk and location in relation to prospective clinical assessment of foot shape and mobility among persons with diabetes. Diabetes Res Clin Pract82: 226, 2008.
CowleyMS, BoykoEJ, ShoferJB, et al: Foot ulcer risk and location in relation to prospective clinical assessment of foot shape and mobility among persons with diabetes. Diabetes Res Clin Pract82: 226, 2008.10.1016/j.diabres.2008.07.02518829126http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000261597600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3)| true
MohamedO, CernyK, RojekL, et al: The effects of PLASTAZOTE and ALIPLAST/PLASTAZOTE orthoses on plantar pressures in elderly persons with diabetic neuropathy. J Prosthet Orthot16: 55, 2004.10.1097/00008526-200404000-00005)| false
PatonJ, JonesRB, StenhouseE, et al: The physical characteristics of materials used in the manufacture of orthoses for patients with diabetes. Foot Ankle Int28: 1057, 2007.17923055http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250072100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.3113/FAI.2007.1057)| true
Insoles are commonly used to assist in the prevention of diabetic neuropathic foot ulceration. Insole replacement is often triggered only when foot lesions deteriorate, an indicator that functional performance is comprised and patients are exposed to unnecessary ulcer risk. We investigated the durability of insoles used for ulcer prevention in neuropathic diabetic feet over 12 months.
Sixty neuropathic individuals with diabetes were provided with insoles and footwear. Insole durability over 12 months was evaluated using an in-shoe pressure measurement device and through repeated measurement of material depth at the first metatarsal head and the heel seat. Analysis of variance was performed to assess change across time (at issue, 6 months, and 12 months).
Analyses were conducted using all available data (n = 43) and compliant data (n = 18). No significant difference was found in the reduction of mean peak pressure tested across time (P < .05). For both sites, significant differences in insole depth were identified between issue and 6 months and between issue and 12 months but not between 6 and 12 months (P < .05). Most insole compression occurred during the initial 6 months.
Visual material compression does not seem to be a reliable indicator of insole usefulness. Frequency of insole replacement is best informed by a functional review of effect determined using an in-shoe pressure measurement system. These results suggest that insoles for diabetic neuropathic patients can be effective in maintaining peak pressure reduction for 12 months regardless of wear frequency.
Corresponding author: Joanne S. Paton, PhD, Faculty of Health and Human Sciences, Plymouth University, FF21 Peninsula Allied Health Centre, Derriford Road, Plymouth, PL6 9BH, England. (E-mail: firstname.lastname@example.org)